More importantly, our dual-luciferase assay confirmed the targeting relationship between OIP5-AS1 and miR-410, suggesting that OIP5-AS1 may play roles in glioma pathogenesis and progression by modulation of miR-410. The gene discussed is OIP5; the disease is central nervous system cancer.